Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

NCT03772132 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma of the Extrahepatic Bile Duct
Gallbladder Cancer

Interventions

BIOLOGICAL: mutation and signal pathway activation status analysis Drug: FORFIRINOX

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]